Literature DB >> 21486950

Phosphorylation controls a dual-function polybasic nuclear localization sequence in the adapter protein SH2B1β to regulate its cellular function and distribution.

Travis J Maures1, Hsiao-Wen Su, Lawrence S Argetsinger, Sergio Grinstein, Christin Carter-Su.   

Abstract

An intriguing question in cell biology is what targets proteins to, and regulates their translocation between, specific cellular locations. Here we report that the polybasic nuclear localization sequence (NLS) required for nuclear entry of the adapter protein and candidate human obesity gene product SH2B1β, also localizes SH2B1β to the plasma membrane (PM), most probably via electrostatic interactions. Binding of SH2B1β to the PM also requires its dimerization domain. Phosphorylation of serine residues near this polybasic region, potentially by protein kinase C, releases SH2B1β from the PM and enhances nuclear entry. Release of SH2B1β from the PM and/or nuclear entry appear to be required for SH2B1β enhancement of nerve growth factor (NGF)-induced expression of urokinase plasminogen activator receptor gene and neurite outgrowth of PC12 cells. Taken together, our results provide strong evidence that the polybasic NLS region of SH2B1 serves the dual function of localizing SH2B1 to both the nucleus and the PM, the latter most probably through electrostatic interactions that are enhanced by SH2B1β dimerization. Cycling between the different cellular compartments is a consequence of the phosphorylation and dephosphorylation of serine residues near the NLS and is important for physiological effects of SH2B1, including NGF-induced gene expression and neurite outgrowth.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21486950      PMCID: PMC3078818          DOI: 10.1242/jcs.078949

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  49 in total

1.  Mutational and biochemical analysis of plasma membrane targeting mediated by the farnesylated, polybasic carboxy terminus of K-ras4B.

Authors:  M O Roy; R Leventis; J R Silvius
Journal:  Biochemistry       Date:  2000-07-18       Impact factor: 3.162

2.  SH2-B and APS are multimeric adapters that augment TrkA signaling.

Authors:  X Qian; D D Ginty
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  SH2-B is required for growth hormone-induced actin reorganization.

Authors:  J Herrington; M Diakonova; L Rui; D R Gunter; C Carter-Su
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

4.  The urokinase plasminogen activator receptor (UPAR) is preferentially induced by nerve growth factor in PC12 pheochromocytoma cells and is required for NGF-driven differentiation.

Authors:  R Farias-Eisner; L Vician; A Silver; S Reddy; S A Rabbani; H R Herschman
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

5.  Four PSM/SH2-B alternative splice variants and their differential roles in mitogenesis.

Authors:  N Yousaf; Y Deng; Y Kang; H Riedel
Journal:  J Biol Chem       Date:  2001-08-13       Impact factor: 5.157

Review 6.  Signal-dependent membrane targeting by pleckstrin homology (PH) domains.

Authors:  M A Lemmon; K M Ferguson
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

7.  A new highly penetrant form of obesity due to deletions on chromosome 16p11.2.

Authors:  R G Walters; S Jacquemont; A Valsesia; A J de Smith; D Martinet; J Andersson; M Falchi; F Chen; J Andrieux; S Lobbens; B Delobel; F Stutzmann; J S El-Sayed Moustafa; J-C Chèvre; C Lecoeur; V Vatin; S Bouquillon; J L Buxton; O Boute; M Holder-Espinasse; J-M Cuisset; M-P Lemaitre; A-E Ambresin; A Brioschi; M Gaillard; V Giusti; F Fellmann; A Ferrarini; N Hadjikhani; D Campion; A Guilmatre; A Goldenberg; N Calmels; J-L Mandel; C Le Caignec; A David; B Isidor; M-P Cordier; S Dupuis-Girod; A Labalme; D Sanlaville; M Béri-Dexheimer; P Jonveaux; B Leheup; K Ounap; E G Bochukova; E Henning; J Keogh; R J Ellis; K D Macdermot; M M van Haelst; C Vincent-Delorme; G Plessis; R Touraine; A Philippe; V Malan; M Mathieu-Dramard; J Chiesa; B Blaumeiser; R F Kooy; R Caiazzo; M Pigeyre; B Balkau; R Sladek; S Bergmann; V Mooser; D Waterworth; A Reymond; P Vollenweider; G Waeber; A Kurg; P Palta; T Esko; A Metspalu; M Nelis; P Elliott; A-L Hartikainen; M I McCarthy; L Peltonen; L Carlsson; P Jacobson; L Sjöström; N Huang; M E Hurles; S O'Rahilly; I S Farooqi; K Männik; M-R Jarvelin; F Pattou; D Meyre; A J Walley; L J M Coin; A I F Blakemore; P Froguel; J S Beckmann
Journal:  Nature       Date:  2010-02-04       Impact factor: 49.962

8.  Nucleocytoplasmic shuttling of the adapter protein SH2B1beta (SH2-Bbeta) is required for nerve growth factor (NGF)-dependent neurite outgrowth and enhancement of expression of a subset of NGF-responsive genes.

Authors:  Travis J Maures; Linyi Chen; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2009-04-16

9.  Adapter protein SH2B1beta cross-links actin filaments and regulates actin cytoskeleton.

Authors:  Leah Rider; Jing Tao; Stacy Snyder; Brittany Brinley; Jiayun Lu; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2009-04-02

10.  Large, rare chromosomal deletions associated with severe early-onset obesity.

Authors:  Elena G Bochukova; Ni Huang; Julia Keogh; Elana Henning; Carolin Purmann; Kasia Blaszczyk; Sadia Saeed; Julian Hamilton-Shield; Jill Clayton-Smith; Stephen O'Rahilly; Matthew E Hurles; I Sadaf Farooqi
Journal:  Nature       Date:  2009-12-06       Impact factor: 49.962

View more
  8 in total

1.  The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor.

Authors:  Mojib Javadi; Edda Hofstätter; Natalie Stickle; Bryan K Beattie; Robert Jaster; Christin Carter-Su; Dwayne L Barber
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  SH2B1 and IRSp53 proteins promote the formation of dendrites and dendritic branches.

Authors:  Chien-Jen Chen; Chien-Hung Shih; Yu-Jung Chang; Shao-Jing Hong; Tian-Neng Li; Lily Hui-Ching Wang; Linyi Chen
Journal:  J Biol Chem       Date:  2015-01-13       Impact factor: 5.157

Review 3.  SH2B1 regulation of energy balance, body weight, and glucose metabolism.

Authors:  Liangyou Rui
Journal:  World J Diabetes       Date:  2014-08-15

4.  Phosphorylation of the Unique C-Terminal Tail of the Alpha Isoform of the Scaffold Protein SH2B1 Controls the Ability of SH2B1α To Enhance Nerve Growth Factor Function.

Authors:  Ray M Joe; Anabel Flores; Michael E Doche; Joel M Cline; Erik S Clutter; Paul B Vander; Heimo Riedel; Lawrence S Argetsinger; Christin Carter-Su
Journal:  Mol Cell Biol       Date:  2018-02-27       Impact factor: 4.272

5.  Identification of SH2B1β as a focal adhesion protein that regulates focal adhesion size and number.

Authors:  Nathan J Lanning; Hsiao-Wen Su; Lawrence S Argetsinger; Christin Carter-Su
Journal:  J Cell Sci       Date:  2011-08-30       Impact factor: 5.285

6.  The nucleolar δ isoform of adapter protein SH2B1 enhances morphological complexity and function of cultured neurons.

Authors:  Jessica L Cote; Paul B Vander; Michael Ellis; Joel M Cline; Nadezhda Svezhova; Michael E Doche; Travis J Maures; Tahrim A Choudhury; Seongbae Kong; Olivia G J Klaft; Ray M Joe; Lawrence S Argetsinger; Christin Carter-Su
Journal:  J Cell Sci       Date:  2022-02-10       Impact factor: 5.235

7.  Phosphorylation of the adaptor protein SH2B1β regulates its ability to enhance growth hormone-dependent macrophage motility.

Authors:  Hsiao-Wen Su; Nathan J Lanning; David L Morris; Lawrence S Argetsinger; Carey N Lumeng; Christin Carter-Su
Journal:  J Cell Sci       Date:  2013-02-26       Impact factor: 5.285

8.  Crucial Role of the SH2B1 PH Domain for the Control of Energy Balance.

Authors:  Anabel Flores; Lawrence S Argetsinger; Lukas K J Stadler; Alvaro E Malaga; Paul B Vander; Lauren C DeSantis; Ray M Joe; Joel M Cline; Julia M Keogh; Elana Henning; Ines Barroso; Edson Mendes de Oliveira; Gowri Chandrashekar; Erik S Clutter; Yixin Hu; Jeanne Stuckey; I Sadaf Farooqi; Martin G Myers; Christin Carter-Su
Journal:  Diabetes       Date:  2019-08-22       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.